Moddy's Positive on Clorox's (CLX) Acquisition of Renew Life; No Ratings Impact Expected
Get Alerts CLX Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Down)
Dividend Yield: 3.3%
Revenue Growth %: -2.6%
Join SI Premium – FREE
Moody's Investors Service commented that The Clorox Company's (NYSE: CLX) announced acquisition of Renew Life Holding Corporation is credit positive, but has no effect on the company's ratings. On May 3, 2016, Clorox announced it had acquired Renew Life, a producer of digestive wellness supplements, for approximately $290 million. For more details please see the Issuer Comment published May 3, 2016. This publication does not announce a credit rating action. For any credit ratings referenced in this publication, please see the ratings tab on the issuer/entity page on www.moodys.com for the most updated credit rating action information and rating history.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Global (PARA) and Skydance are closer to a merger - CNBC
- IBM (IBM) PT Lowered to $179 at Morgan Stanley, 'shares are largely fair valued'
- XOMA (XOMA) Earns $9M Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM
Create E-mail Alert Related Categories
Credit RatingsRelated Entities
Moody's Investors Service, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!